STEX is expected to report earnings to fall 87.50% to 0 cents per share on November 12
Q3'26
Est.
$-0.01
Q2'26
Missed
by $0.06
Q1'26
Missed
by $0.22
Q4'25
Missed
by $3.63
Q3'25
Missed
by $0.11
The last earnings report on August 14 showed earnings per share of -7 cents, missing the estimate of -1 cents. With 765.18K shares outstanding, the current market capitalization sits at 97.04M.
A.I. Advisor
published General Information
General Information
a development stage company which develops medical devices
A.I.dvisor indicates that over the last year, STEX has been loosely correlated with KEEL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STEX jumps, then KEEL could also see price increases.
STEX's RSI Indicator peaks and leaves overbought zone
The 10-day RSI Oscillator for STEX moved out of overbought territory on August 17, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 instances where the indicator moved out of the overbought zone. In of the 32 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
Technical Analysis (Indicators)
Bearish Trend Analysis
STEX moved below its 50-day moving average on August 18, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STEX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
STEX broke above its upper Bollinger Band on August 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for STEX entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where STEX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 19, 2026. You may want to consider a long position or call options on STEX as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for STEX just turned positive on August 03, 2026. Looking at past instances where STEX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for STEX crossed bullishly above the 50-day moving average on August 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STEX advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.666) is normal, around the industry mean (4.401). P/E Ratio (0.000) is within average values for comparable stocks, (21.328). STEX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.691). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. STEX's P/S Ratio (714.286) is very high in comparison to the industry average of (17.980).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
